A new study has unveiled when chronic myeloid leukaemia, a type of cancer that affects the blood and bone marrow, arises in ...

A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following ...

A new, AI-powered test can detect the molecular "fingerprints" of cancer in a patient's blood using flashes of infrared light ...

As of 2022, more than 800 new cell therapies are being developed for five blood cancers, with the market for oncology cell therapies expected to exceed $37 billion in value globally by 2028.

A paper published in Scientific Reports focuses on improving blood cancer diagnoses using advanced deep learning techniques correctly identified blood cancer in 97% of cases 1. A team led by Mona ...

Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Now, research ...

Drug in Clinical Trials for Breast Cancer Could Also Treat Some Blood Cancers Jan. 16, 2025 — Two new studies have identified a possible way to block the progression of several forms of blood ...

MSD has kicked off a new phase 3 trial of its oral LSD1 inhibitor bomedemstat in essential thrombocythaemia (ET), one of a rare type of blood cancer known as myeloproliferative neoplasms (MPNs).

Feb. 10, 2025 — When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The ...

Researchers at Moffitt Cancer Center have found that tapping into the body's own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness ...

CLL is a slow-growing cancer that can take years to get worse. Many people with CLL don’t show symptoms for several years. Over time, CLL can lead to problems such as a low level of red blood ...